EV-D68 more commonly causes respiratory illness, while EV-A71 and CV-A6 can cause hand, foot, and mouth disease. While EV-D68 is usually asymptomatic or causes only mild symptoms, it can, in rare ...

Arexvy was the first vaccine approved to prevent respiratory syncytial virus (RSV). RSV is a common virus that usually causes mild cold-like symptoms. These symptoms can be more severe in babies ...

This alarm system can help your body fight off the RSV virus and prevent severe cases of it. RSV vaccines don’t include mRNA technology like the Pfizer and BioNtech COVID-19 vaccines do.

Last accessed: October 2024 7 A.Njue et al., “Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income Countries ...

Moderna reports that its recent ConquerRSV Phase III pivotal efficacy trial demonstrated a vaccine efficiency of 83.7% against RSV-lower respiratory tract disease (defined in older adults by two ...

Respiratory syncytial virus co-infections might conspire to worsen disease Emerging evidence suggests that pathogens can pair up to work together against immune system defences. By ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...